Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications

Annals of the New York Academy of Sciences

Volumn 1071, Issue , 2006, Pages 137-166

  Yehuda, Rachel ^a,b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Bronx VA OOMH   (United States)

Author keywords

Cortisol; Hypothalamic pituitary adrenal axis; Neuroendocrine alterations; Novel therapeutic strategies; Posttraumatic stress disorder

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; TRANSCORTIN;

BLOOD SAMPLING; CIRCADIAN RHYTHM; CONFERENCE PAPER; CORTICOTROPIN BLOOD LEVEL; DEXAMETHASONE SUPPRESSION TEST; DISEASE MARKER; DISEASE SEVERITY; ENDOCRINE FUNCTION TEST; EPIGENETICS; FOLLOW UP; GAS CHROMATOGRAPHY; GENETIC EPIGENESIS; HIPPOCAMPUS; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MASS SPECTROMETRY; MENTAL DISEASE; NEGATIVE FEEDBACK; NEUROPSYCHIATRY; NEUROSECRETORY CELL; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; RADIOIMMUNOASSAY; SALIVA ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOM; URINALYSIS; URINARY EXCRETION;

EID: 33746433010     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1364.012     Document Type: Conference Paper

References (150)

1. VAIVA, G. et al. 2003. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol. Psychiatry 54: 947-949.
2. SCHELLING, G. et al. 2004. Can posttraumatic stress disorder be prevented with glucocorticoids? Ann. N. Y. Acad. Sci. 1032: 158-166.
3. AERNI, A. et al. 2004. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am. J. Psychiatry 161: 1488-1490.
4. SCHELLING, G. et al. 2004. Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study. Biol. Psychiatry 55: 627-633.
5. MASON, J.W. et al. 1986. Urinary free-cortisol levels in posttraumatic stress disorder patients. J. Nerv. Ment. Dis. 174: 145-149.
6. SAPOLSKY, R.M. 1986. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. [review] 7: 284-301.
7. YEHUDA, R. 2002. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr. Clin. North Am. [review] 25: 341-368.
8. YEHUDA, R. et al. 1990. Low urinary cortisol excretion in patients with posttraumatic stress disorder. J. Nerv. Ment. Dis. 178: 366-369.
9. YEHUDA, R. et al. 1993. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol. Psychiatry 34: 18-25.
10. YEHUDA, R. et al. 1995. Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am. J. Psychiatry 152: 982-986.
11. YEHUDA, R. et al. 1996. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiatry 40: 79-88.
12. HEIM, C. et al. 1998. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom. Med. 60: 309-318.
13. GLOVER, D.A. et al. 2002. Urinary cortisol and catecholamines in mothers of child cancer survivors with and without PTSD. Psychoneuroendocrinology 27: 805-819.
14. BREMNER, J.D. et al. 2003. Assessment of the hypothalamic-pituitary- adrenal axis over a 24-hour diurnal period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder. Biol. Psychiatry 54: 710-718.
15. Retraction in: 2004 Biol. Psychiatry 55: 1202.
16. PITMAN, R.K. et al. 1990. Twenty-four hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder. Biol. Psychiatry 27: 245-247.
17. LEMIEUX, A.M. et al. 1995. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom. Med. 57: 105-115.
18. MAES, M. et al. 1998. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta. Psychiatr. Scand. 98: 328-335.
19. BAKER, D.G. et al. 1999. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am. J. Psychiatry 156: 585-588.
20. RASMUSSON, A.M. et al. 2001. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol. Psychiatry 50: 965-977. Erratum in: Biol. Psychiatry 2002.
21. BOSCARINO, J.A. 1996. Posttraumatic stress disorder, exposure to combat, and lower plasma cortisol among Vietnam veterans: findings and clinical implications. J. Consult. Clin. Psychol. 64: 191-201.
22. YOUNG, E.A. et al. 2004. Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch. Gen. Psychiatry 61: 394-401.
23. YOUNG, E.A. et al. 2004. Saliva cortisol in posttraumatic stress disorder: a community epidemiologic study. Biol. Psychiatry 56: 205-209.
24. ANISMAN, H. et al. 2001. Posttraumatic stress symptoms and salivary cortisol levels. Am. J. Psychiatry 158: 1509-1511.
25. AARDAL-ERIKSSON, E. et al. 2001. Salivary cortisol, posttraumatic stress symptoms, and general health in the acute phase and during 9-month follow-up. Biol. Psychiatry 50: 986-993.
26. MASON, J.W. et al. 2002. Marked lability in urinary cortisol levels in subgroups of combat veterans with posttraumatic stress disorder during an intensive exposure treatment program. Psychosom. Med. 64: 238-246.
27. KELLNER, M. et al. 2002. Longitudinal course of salivary cortisol in posttraumatic stress disorder. Acta. Psychiatr. Scand. 105: 153-155; discussion 155, 156.
28. SONDERGAARD, H.P. et al. 2003. A longitudinal study of hormonal reactions accompanying life events in recently resettled refugees. Psychother. Psychosom. 72: 49-58.
29. DELAHANTY, D.L. et al. 2003. Injury severity, prior trauma history, urinary cortisol levels, and acute PTSD in motor vehicle accident victims. J. Anxiety Disord. 17: 149-164.
30. HEINRICHS, M. et al. 2005. Predicting posttraumatic stress symptoms from pretraumatic risk factors: a 2-year prospective follow-up study in firefighters. Am. J. Psychiatry 162: 2276-2286.
31. BONNE, O. et al. 2003. Prospective evaluation of plasma cortisol in recent trauma survivors with posttraumatic stress disorder. Psychiatry Res. 119: 171-175.
32. JENSEN, C.F. et al. 1997. Behavioral and neuroendocrine responses to sodium lactate infusion in subject with posttraumatic stress disorder. Am. J. Psychiatry 154: 266-268.
33. ROHLEDER, N. et al. 2001. Sex differences in glucocorticoid sensitivity of proinfiammatory cytokine production after psychosocial stress. Psychosom. Med. 63: 966-972.
34. ALTEMUS, M. et al. 2003. Enhanced cellular immune response in women with PTSD related to childhood abuse. Am. J. Psychiatry 160: 1705-1707.
35. LINDAUER, R.J. et al. 2005. Cortisol, learning, memory, and attention in relation to smaller hippocampal volume in police officers with PTSD. Biol. Psychiatry 59: 171-177.
36. YEHUDA, R. et al. 2005. Relationship between cortisol and age-related memory impairments in Holocaust survivors with PTSD. Psychoneuroendocrinology 30: 678-687.
37. VYTHILINGAM, M. et al. 2006. Hydrocortisone impairs hippocampal-dependent trace eyeblink conditioning in post-traumatic stress disorder. Neuropsychopharmacology 31: 182-188.
38. KELLNER, M. et al. 2003. Endocrine and cardiovascular responses to corticotropin-releasing hormone in patients with posttraumatic stress disorder: a role for atrial natriuretic peptide? Neuropsychobiology 47: 102-108.
39. SENG, J.S. et al. 2005. Cortisol level and perinatal outcome in pregnant women with posttraumatic stress disorder: a pilot study. J. Midwifery Womens Health 50: 392-398.
40. OTTE, C. et al. 2005. Hypothalamic-pituitary adrenal axis activity and sleep in posttraumatic stress disorder. Neuropsychopharmacology 30: 1173-1180.
41. HEIM, C. et al. 2002. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress. Anxiety 15: 117-125.
42. ELZINGA, B.M. et al. 2003. Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology 28: 1656-1665.
43. BREMNER, J.D. et al. 2003. Cortisol response to a cognitive stress challenge in posttraumatic stress disorder (PTSD) related to childhood abuse. Psychoneuroendocrinology 28: 733-750.
44. LIBERZON, I. et al. 1999. Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology 21: 40-50.
45. TUCKER, P. et al. 2004. Paroxetine treatment of depression with posttraumatic stress disorder: effects on autonomie reactivity and cortisol secretion. J. Clin. Psychopharmacol. 24: 131-140.
46. RAISON, C.L. et al. 2003. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry [review] 160: 1554-1565.
47. RESNICK, H.S. et al. 1995. Effect of previous trauma on acute plasma cortisol level following rape. Am. J. Psychiatry 152: 1675-1681.
48. YEHUDA, R. et al. 1998. Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event. Biol. Psychiatry [review] 44: 1305-1313.
49. ANISMAN, H. et al. 2001. Posttraumatic stress symptoms and salivary cortisol levels. Am. J. Psychiatry 158: 1509-1511.
50. DELAHANTY, D.L. et al. 2000. Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol. Psychiatry 48: 940-947.
51. DELAHANTY, D.L. et al. 2003. Injury severity, prior trauma history, urinary cortisol levels, and acute PTSD in motor vehicle accident victims. J. Anxiety Disord. 17: 149-164.
52. YEHUDA, R. 2002. Post-traumatic stress disorder. N. Engl. J. Med. [review] 346: 108-114.
53. DE KLOET, E.R. et al. 2005. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6: 653-675.
54. YEHUDA, R. et al. 2000. Low cortisol and risk for PTSD in adult offspring of holocaust survivors. Am. J. Psychiatry 157: 1252-1259.
55. GOENJIAN, A.K. et al. 2003. Hypothalamic-pituitary-adrenal activity among Armenian adolescents with PTSD symptoms. J. Trauma. Stress 16: 319-323.
56. YEHUDA, R. et al. 2001. Childhood trauma and risk for PTSD: relationship to intergenerational effects of trauma, parental PTSD, and cortisol excretion. Dev. Psychopathol. 13: 733-753.
57. NEYLAN, T.C. et al. 2005. PTSD symptoms predict waking salivary cortisol levels in police officers. Psychoneuroendocrinology 30: 373-381.
58. LUECKEN, L.J. et al. 2004. Alterations in morning cortisol associated with PTSD in women with breast cancer. J. Psychosom. Res. 56: 13-15.
59. BACHMANN, A. W. et al. 2005. Glucocorticoid receptor polymorphisms and posttraumatic stress disorder. Psychoneuroendocrinology 30: 297-306.
60. NEYLAN, T.C. et al. 2003. Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol. Psychiatry 54: 1118-1121.
61. BONNE, O. et al. 2003. Resting regional cerebral perfusion in recent posttraumatic stress disorder. Biol. Psychiatry 54: 1077-1086.
62. THALLER, V. et al. 1999. The potential role of hypocortisolism in the pathophysiology of PTSD and psoriasis. Coll. Antropol. 23: 611-619.
63. HOFFMANN, L. et al. 1989. Low plasma b-endorphin in posttraumatic stress disorder. Aust. N. Z. J. Psychiatry 23: 269-273.
64. YEHUDA, R. et al. 2005. Circadian rhythm of salivary cortisol in Holocaust survivors with and without PTSD. Am. J. Psychiatry 162: 998-1000.
65. WESSA, M. et al. 2006. Altered cortisol awakening response in posttraumatic stress disorder. Psychoneuroendocrinology 31: 209-215.
66. YOUNG, E.A. et al. 2004. Salivary cortisol and posttraumatic stress disorder in a low-income community sample of women. Biol. Psychiatry 55: 621-626.
67. BREMNER, J.D. et al. 1997. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry 154: 624-629.
68. SAUTTER, F.J. et al. 2003. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol. Psychiatry 54: 1382-1388.
69. KASCKOW, J.W. et al. 2001. Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides [review] 22: 845-851.
70. YEHUDA, R. et al. 1993. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am. J. Psychiatry 150: 83-86.
71. YEHUDA, R. et al. 1995. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch. Gen. Psychiatry 52: 583-593.
72. GOENJIAN, A.K. et al. 1996. Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in Armenia. Am. J. Psychiatry 153: 929-934.
73. STEIN, M.B. et al. 1997. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol. Psychiatry 42: 680-686.
74. KELENER, M. et al. 1997. Salivary cortisol and PTSD symptoms in Persian Gulf War combatants. Ann. N. Y. Acad. Sci. 821: 442-443.
75. GROSSMAN, R. et al. 2001. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression. Am. J. Psychiatry 160: 1291-1298.
76. RINNE, T. et al. 2002. Hyperresponsiveness of hypothalamic-pituitary- adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol. Psychiatry 52: 1102-1112.
77. YEHUDA, R. et al. 2002. The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol. Psychiatry 52: 393-403.
78. LANGE, W. et al. 2005. Dexamethasone suppression test in borderline personality disorder-effects of posttraumatic stress disorder. Psychoneuroendocrinology 20: 919-923.
79. DUVAL, F. et al. 2004. Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Psychoneuroendocrinology 29: 1281-1289.
80. YEHUDA, R. et al. 2004. Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology 29: 389-404.
81. YEHUDA, R. et al. 2002. The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol. Psychiatry 52: 393-403.
82. YEHUDA, R. et al. 2004. The ACTH response to dexamethasone in PTSD. Am. J. Psychiatry 161: 1397-1403.
83. NEWPORT, D.J. et al. 2004. Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol. Psychiatry 55: 10-20.
84. GRIFFIN, M.G. et al. 2005. Enhanced cortisol suppression following dexamethasone administration in domestic violence survivors. Am. J. Psychiatry 162: 1192-1199.
85. LANGE, W. et al. 2005. Dexamethasone suppression test in borderline personality disorder-effects of posttraumatic stress disorder. Psychoneuroendocrinology 30: 919-923.
86. LINDLEY, S.E. et al. 2004. Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder. Biol. Psychiatry 55: 940-945.
87. ATMACA, M. et al. 2002. Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder. Eur. Arch. Psychiatry Clin. Neurosci. 252: 161-165.
88. LIPSCHITZ, D.S. et al. 2003. Salivary cortisol responses to dexamethasone in adolescents with posttraumatic stress disorder. J. Am. Acad. Child. Adolesc. Psychiatry 42: 1310-1317.
89. YEHUDA, R. et al. 2006. Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD. Psychoneuroendocrinology 31: 447-451.
90. ROHLEDER, N. et al. 2004. Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol. Psychiatry 55: 745-751.
91. COUPLAND, N.J. et al. 2003. Increased beclomethasone-induced vasoconstriction in women with posttraumatic stress disorder. J. Psychiatr. Res. 37: 221-228.
92. YEHUDA, R. et al. 2004. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 55: 1110-1116.
93. GOTOVAC, K. et al. 2003. Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clin. Exp. Immunol. 131: 335-339.
94. YEHUDA, R. et al. 1991. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am. J. Psychiatry 148: 499-504.
95. STROHLE, A. et al. 2003. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry [review] 36(Suppl 3): S207-S214.
96. HOLSBOER, F. 2003. Corticotropin-releasing hormone modulators and depression. Curr. Opin. Investig. Drugs [review] 4: 46-50.
97. HOLSBOER, F. 2000. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology [review] 23: 477-501.
98. DINAN, T.G. et al. 1990. A pilot study of a neuroendocrine test battery in posttraumatic stress disorder. Biol. Psychiatry 28: 665-672.
99. HALBREICH, U. et al. 1989. Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients. Psychoneuroendocrinology 14: 365-370.
100. KOSTEN, T.R. et al. 1990. The dexamethasone suppression test and thyrotropin-releasing hormone stimulation test in posttraumatic stress disorder. Biol. Psychiatry 28: 657-664.
101. REIST, C. et al. 1995. REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder. Prog. Neuro-psychopharmacol. Biol. Psychiat. 19: 433-443.
102. KUDLER, H. et al. 1987. The DST and posttraumatic stress disorder. Am. J. Psychiatry 14: 1058-1071.
103. KANTER, E.D. et al. 2001. Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder. Biol. Psychiatry 50: 238-245.
104. YEHUDA, R. et al. 1996. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology 21: 1-16.
105. KELLNER, M. et al. 2004. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings. Eur. Neuropsychopharmacol. 14: 337-339.
106. NEYLAN, T.C. et al. 2003. Delta sleep response to metyrapone in post-traumatic stress disorder. Neuropsychopharmacology 28: 1666-1676.
107. SMITH, M.A. et al. 1989. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol. Psychiatry 26: 349-355.
108. KELLNER, M. et al. 2003. Endocrine and cardiovascular responses to corticotropin-releasing hormone inpatients with posttraumatic stress disorder: a role for atrial natriuretic peptide? Neuropsychobiology 47: 102-108.
109. RUPPRECHT, R. et al. 1989. Blunted adrenocorticotropin but normal beta-endorphin release after human corticotropin-releasing hormone administration in depression. J. Clin. Endocrinol. Metab. 69: 600-603.
110. VON BARDELEBEN, U. et al. 1988. Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment. Biol. Psychiatry 24: 782-786.
111. HOLSBOER, F. et al. 1987. Blunted aldosterone and ACTH release after human CRH administration in depressed patients. Am. J. Psychiatry 144: 229-231.
112. DE KLOET, E.R. et al. 1991. Implication of brain corticosteroid receptor diversity for the adaptation syndrome concept. Methods Achiev. Exp. Pathol. [review] 14: 104-132.
113. SAPOLSKY, R.M. et al. 1984. Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology 114: 287-292.
114. LOWY, M.T. 1989. Quantification of type I and II adrenal steroid receptors in neuronal, lymphoid and pituitary tissues. Brain Res. 503: 191-197.
115. GORMLEY, G.J. et al. 1985. Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test. Am. J. Psychiatry 142: 1278-1284.
116. KELLNER, M. et al. 2002. Mineralocorticoid receptor function in patients with posttraumatic stress disorder. Am. J. Psychiatry 159: 1938-1940.
117. MCCORMICK, J.A. et al. 2000. 5′-heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcripts by early-life events. Mol. Endocrinol. 14: 506-517.
118. BINDER, E.B. et al. 2004. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 36: 1319-1325.
119. YEHUDA, R. et al. 2003. Relationship between dexamethasone-inhibited lysozyme activity in peripheral mononuclear leukocytes and the cortisol and glucocorticoid receptor response to dexamethasone. J. Psychiatr. Res. 37: 471-477.
120. HOESBOER, F. et al. 1982. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. J. Affect. Disord. 4: 93-101.
121. MENDLEWICZ, J. et al. 1984. Further investigation of the dexamethasone suppression test in affective illnesses: relationship to clinical diagnosis and therapeutic response. Neuropsychobiology 12: 23-26.
122. BOWIE, P.C. et al. 1985. Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives. Br. J. Psychiatry 147: 30-35.
123. ZOBEL, A. W. et al. 2001. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J. Psychiatr. Res. 35: 83-94.
124. YEHUDA, R. et al. under review. Enhanced cortisol suppression following 0.50 mg dexamethasone in adult offspring of Holocaust survivors with parental PTSD. Am. J. Psychol.
125. ISING, M. et al. 2005. The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands. J. Psychiatr. Res. 39: 21-28.
126. GERACIOTI, T.D. et al. 2001. CSF norepinephrine concentrations in posttraumatic stress disorder. Am. J. Psychiatry 158: 1227-1230.
127. HAWK, L.W. et al. 2000. Urinary catecholamines and cortisol in recent-onset posttraumatic stress disorder after motor vehicle accidents. Psychosom. Med. 62: 423-434.
128. SOUTHWICK, S.M. et al. 1999. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol. Psychiatry [review] 46: 1192-1204.
129. LIBERZON, I. et al. 1999. Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology 21: 40-50.
130. YEHUDA, R. et al. 1998. Plasma norepinephrine and 3-methoxy-4- hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biol. Psychiatry 44: 56-63.
131. YEHUDA, R. et al. 2005. Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J. Clin. Endocrinol. Metab. 90: 4115-4118.
132. YEHUDA, R., et al. 2002. Cortisol levels in adult offspring of Holocaust survivors: relation to PTSD symptom severity in the parent and child. Psychoneuroendocrinology 27: 171-180.
133. SECKL, J.R. et al. 2004. Glucocorticoid programming. Ann. N. Y. Acad. Sci. [review] 1032: 63-84.
134. SECKL, J.R. 2004. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. [review] 151(Suppl 3): U49-U62.
135. NOVIK, K.L. et al. 2002. Epigenomics: genome-wide study of methylation phenomena. Curr. Issues. Mol. Biol. [review] 4: 111-128.
136. NAKAO, M. 2001. Epigenetics: interaction of DNA methylation and chromatin. Gene [review] 278: 25-31.
137. HOLLIDAY, R. 1989. DNA methylation and epigenetic mechanisms. Cell. Biophys. [review] 15: 15-20.
138. SUTHERLAND, J.E. et al. 2003. Epigenetics and the environment. Ann. N. Y. Acad. Sci. [review] 983: 151-160.
139. WEAVER, I.C. et al. 2002. From maternal care to gene expression: DNA methylation and the maternal programming of stress responses. Endocr. Res. 28: 699.
140. WEAVER, I.C. et al. 2004. Epigenetic programming by maternal behavior. Nat. Neurosci. 7: 847-854.
141. NISHITH, P. et al. 2000. Prior interpersonal trauma: the contribution to current PTSD symptoms in female rape victims. J. Abnorm. Psychol. 109: 20-25.
142. EPSTEIN, J.N. et al. 1997. Predicting PTSD in women with a history of childhood rape. J. Trauma. Stress 10: 573-588.
143. ANDREWS, B. et al. 2000. Predicting PTSD symptoms in victims of violent crime: the role of shame, anger, and childhood abuse. J. Abnorm. Psychol. 109: 69-73.
144. YEHUDA, R. et al. 2001. Relationship between childhood traumatic experiences and PTSD in adults. Ann. Rev. Psychiatry 20: 117-158.
145. LIU, D. et al. 1997. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277: 1659-1662.
146. ESTELLER, M. 2005. Aberrant DNA methylation as a cancer-inducing mechanism. Annu. Rev. Pharmacol. Toxicol. [review] 45: 629-656.
147. KESSLER, R.C. et al. 1995. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 52: 1048-1060.
148. CHAMPAGNE, F. et al. 2001. Like mother, like daughter: evidence for non-genomic transmission of parental behavior and stress responsivity. Prog. Brain Res. [review] 133: 287-302.
149. FRANCIS, D. et al. 1999. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286: 1155-1158.
150. SELYE, H. 1985. The nature of stress. Basal Facts 7: 3-11.